With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop a more resilient healthcare system and innovations.
The urgency for innovation and access in the mental health vertical has never been more pivotal. On a macro level, there has been a global shift in consumer demand for quality health and wellness services and a significant lift in education and affluence in Southeast Asia, presenting a promising context for this industry.
Receiving investment led by East Ventures, mental health startup Riliv maximizes services to help face the pandemic and new normal
Mental health service startup Riliv announced that it has received seed round funding led by East Ventures. Other investors, such as Benson Capital, Sankalpa Ventures, Teja Ventures, Telkom Indonesia through Indigo Acceleration program, and Angel Investor Shweta Shrivastava also participated in this funding round to jointly develop the mental health industry in Indonesia.
Last year, Nalagenetics won its 1st major contract from the Indonesian health ministry to distribute 1,000 genetic test kits in Papua & West Papua.